Indraprastha Medical Corporation: Strong Q1 FY27 Performance

Indraprastha Medical Corporation reported a net profit after tax (PAT) of ₹55.85 crore for the quarter ended June 30, 2026. Revenue from operations stood at ₹406.15 crore.

Reader Takeaway: Profit and revenue growth driven by core operations, with key corporate actions announced.

What just happened

Indraprastha Medical Corporation Ltd has announced its financial results for the first quarter of the fiscal year 2027 (ended June 30, 2026). The company posted a Profit After Tax (PAT) of ₹55.85 crore, a significant increase from ₹51.46 crore in the same quarter last year. Revenue from operations grew to ₹406.15 crore from ₹365.06 crore in the year-ago period.

Why this matters

The improved financial performance, with both profit and revenue showing year-on-year growth, indicates a strengthening business. This positive trend is crucial for investor confidence and reflects the company's operational efficiency and market position.

The backstory

In the previous fiscal year's comparable quarter (June 2025), Indraprastha Medical Corporation had reported a PAT of ₹51.46 crore and revenue of ₹365.06 crore. The current quarter's performance shows a clear upward trajectory compared to both the immediate preceding quarter (March 2026) and the corresponding quarter of the previous year.

What changes now

Shareholders can look forward to key corporate actions. The 38th Annual General Meeting (AGM) is scheduled for September 24, 2026, and the company has fixed September 18, 2026, as the record date to determine entitlement for the dividend for the financial year 2025-26 and for the AGM purposes.

Risks to watch

While the current results are positive, potential risks include market competition and regulatory changes within the healthcare sector. Maintaining this growth momentum will be key.

Peer comparison

(No direct peer comparison data was provided in the filing.)

Context metrics (time-bound)

• Q1 FY27 PAT: ₹55.85 crore (vs. ₹51.46 crore in Q1 FY26, +8.5% YoY).
• Q1 FY27 Revenue: ₹406.15 crore (vs. ₹365.06 crore in Q1 FY26, +11.2% YoY).
• Sequential PAT growth: ₹55.85 crore (Q1 FY27) vs. ₹41.70 crore (Q4 FY26), +34% QoQ.
• Sequential Revenue growth: ₹406.15 crore (Q1 FY27) vs. ₹364.81 crore (Q4 FY26), +11.3% QoQ.

What to track next

Investors should monitor the company's performance in subsequent quarters, its ability to sustain revenue and profit growth, and any updates or outcomes from the upcoming AGM.